Santhera Pharmaceuticals Holding AG: Santhera to Present Financial Figures for 2013 and Outlook at Swiss Biotech Day 2014

Santhera Pharmaceuticals Holding AG: Santhera to Present Financial Figures for
                  2013 and Outlook at Swiss Biotech Day 2014

Santhera Pharmaceuticals Holding AG / Santhera to Present Financial Figures
for 2013 and Outlook at Swiss Biotech Day 2014 . Processed and transmitted by
NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the
content of this announcement.

Liestal, Switzerland, April4, 2014 - Santhera Pharmaceuticals (SIX:SANN)
announced today that Thomas Meier, Chief Executive Officer of Santhera, will
present at the upcoming Swiss Biotech Day on Tuesday, April8, 2014. Mr Meier
will provide an update on forthcoming regulatory and development milestones
and present the financial results for 2013 and for the first quarter of 2014.
The presentation will be available for download on the Company's website
www.santhera.com under Investors/Presentations. In compliance with SIX
regulations, the news release and Annual Report will be published on April8,
2014, at 07:00 CET.

The Swiss Biotech Day is the leading biotechnology conference in Switzerland.
Every year, this event brings together more than 200 senior executives from
the life science industry across Europe. Program highlights will include the
presentation of the Swiss biotech report and key note lectures by renowned
industry leaders and scientists. The event is being held at the Kongresshaus,
Gotthardtrasse 5, in Zurich, Switzerland.

                                    * * *

About Santhera
Santhera Pharmaceuticals (SIX:SANN) is a Swiss specialty pharmaceutical
company focused on the development and commercialization of innovative
pharmaceutical products for the treatment of orphan mitochondrial and
neuromuscular diseases, such as Leber's Hereditary Optic Neuropathy, Duchenne
Muscular Dystrophy and primary progressive Multiple Sclerosis, all of them
areas of high unmet medical need with no current therapies. For further
information, please visit the Company's website www.santhera.com.

For further information, contact
Thomas Meier, Chief Executive Officer
Phone: +41 61 906 89 64
thomas.meier@santhera.com

Disclaimer / Forward-looking statements
This communication does not constitute an offer or invitation to subscribe for
or purchase any securities of Santhera Pharmaceuticals Holding AG. This
publication may contain certain forward-looking statements concerning the
Company and its business. Such statements involve certain risks, uncertainties
and other factors which could cause the actual results, financial condition,
performance or achievements of the Company to be materially different from
those expressed or implied by such statements. Readers should therefore not
place undue reliance on these statements, particularly not in connection with
any contract or investment decision. The Company disclaims any obligation to
update these forward-looking statements.

Swiss Biotech Day

------------------------------------------------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf
of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for
the content, accuracy and originality of the information contained therein.
Source: Santhera Pharmaceuticals Holding AG via Globenewswire
HUG#1774394

--- End of Message ---

Santhera Pharmaceuticals Holding AG
Hammerstrasse 49 Liestal Switzerland

ISIN: CH0027148649;
 
Press spacebar to pause and continue. Press esc to stop.